Clinical Report: Instability of Sepsis Immune Endotypes Challenges Therapeutic Targeting
Overview
Recent analysis reveals frequent and rapid transitions between sepsis immune profiles during ICU stays, exceeding rates expected from biological progression alone. These findings suggest substantial classification error, undermining the reliability of immune endotyping for guiding targeted therapies.
Background
Sepsis is characterized by complex immunological changes, traditionally conceptualized as distinct, stable immune endotypes that evolve predictably over time. Accurate immune profiling could enable personalized immunomodulatory treatments. However, the dynamic nature of immune responses and potential measurement variability complicate the classification of patients into discrete subgroups. Understanding whether observed profile fluctuations reflect true biological progression or classification noise is critical for clinical application.
Data Highlights
Observed 8-hourly transition rates between immune profiles were 41%, 39%, and 22% across three starting profiles, substantially higher than the estimated 15–25% upper bound for biologically plausible changes. The Rand index measuring temporal cohesion was 0.65, indicating that about one-third of patients grouped together initially diverged within 8 hours.
Key Findings
Frequent immune profile transitions occur within 8-hour intervals during ICU admission for sepsis.
Rapid transitions suggest a major contribution of classification error rather than true biological change.
Patients with biomarker values near profile boundaries are disproportionately affected by unstable assignments.
Limited temporal cohesion (Rand index 0.65) indicates poor stability of immune endotype groupings over time.
These instabilities challenge the feasibility of using immune endotypes for reliable patient selection in immunomodulatory therapies.
Clinical Implications
Clinicians should exercise caution when using immune endotyping to guide immunomodulatory treatment in sepsis, given the high likelihood of rapid profile changes and classification instability. Reliance on static or early immune profiles may lead to inappropriate patient selection and suboptimal therapeutic outcomes. Continuous reassessment and improved classification methods are needed to enhance clinical utility.
Conclusion
While sepsis immunological profiles do evolve biologically, the observed rapid and frequent transitions predominantly reflect classification instability. This undermines the current paradigm of stable immune endotypes and limits their practical application in guiding targeted therapies.
References
Ford et al. 2024 -- Response to immune endotype fluctuations in sepsis
Original Study 2024 -- Immune profiling in sepsis ICU patients
Supporting Study 2023 -- Rapid immune changes in emergency department sepsis
